Jarislowsky, Fraser Ltd’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,840
| Closed | -$458K | – | 193 |
|
|
2023
Q2 | $458K | Sell |
12,840
-3,408
| -21% | -$122K | ﹤0.01% | 167 |
|
|
2023
Q1 | $578K | Sell |
16,248
-320
| -2% | -$11.2K | ﹤0.01% | 163 |
|
|
2022
Q4 | $582K | Sell |
16,568
-1,264
| -7% | -$42.1K | ﹤0.01% | 167 |
|
|
2022
Q3 | $524K | Sell |
17,832
-337
| -2% | -$12.8K | ﹤0.01% | 167 |
|
|
2022
Q2 | $988K | Sell |
18,169
-20
| -0.1% | -$1.1K | 0.01% | 151 |
|
|
2022
Q1 | $990K | Sell |
18,189
-1,653
| -8% | -$89.8K | 0.01% | 158 |
|
|
2021
Q4 | $1.09M | Sell |
19,842
-960
| -5% | -$49.9K | 0.01% | 163 |
|
|
2021
Q3 | $993K | Sell |
20,802
-5,760
| -22% | -$289K | ﹤0.01% | 167 |
|
|
2021
Q2 | $1.32M | Sell |
26,562
-3,827
| -13% | -$184K | 0.01% | 160 |
|
|
2021
Q1 | $1.35M | Sell |
30,389
-16,236
| -35% | -$737K | 0.01% | 154 |
|
|
2020
Q4 | $2.14M | Sell |
46,625
-18,156
| -28% | -$834K | 0.01% | 136 |
|
|
2020
Q3 | $3.05M | Sell |
64,781
-3,324
| -5% | -$167K | 0.02% | 125 |
|
|
2020
Q2 | $3.47M | Sell |
68,105
-21,016
| -24% | -$1.08M | 0.02% | 121 |
|
|
2020
Q1 | $4.22M | Sell |
89,121
-2,680
| -3% | -$143K | 0.03% | 111 |
|
|
2019
Q4 | $5.39M | Sell |
91,801
-7,315
| -7% | -$407K | 0.03% | 110 |
|
|
2019
Q3 | $5.29M | Sell |
99,116
-7,772
| -7% | -$400K | 0.03% | 109 |
|
|
2019
Q2 | $5.35M | Sell |
106,888
-30,978
| -22% | -$1.55M | 0.03% | 107 |
|
|
2019
Q1 | $7.2M | Sell |
137,866
-28,192
| -17% | -$1.41M | 0.05% | 106 |
|
|
2018
Q4 | $7.93M | Sell |
166,058
-13,732
| -8% | -$676K | 0.05% | 101 |
|
|
2018
Q3 | $8.78M | Sell |
179,790
-42,964
| -19% | -$2.18M | 0.05% | 104 |
|
|
2018
Q2 | $11.2M | Sell |
222,754
-20,152
| -8% | -$1.01M | 0.07% | 99 |
|
|
2018
Q1 | $11.9M | Sell |
242,906
-63,518
| -21% | -$2.96M | 0.07% | 98 |
|
|
2017
Q4 | $13.6M | Sell |
306,424
-352,941
| -54% | -$16.3M | 0.08% | 95 |
|
|
2017
Q3 | $33.5M | Sell |
659,365
-15,497
| -2% | -$786K | 0.2% | 64 |
|
|
2017
Q2 | $36.4M | Sell |
674,862
-26,030
| -4% | -$1.39M | 0.23% | 66 |
|
|
2017
Q1 | $36.9M | Sell |
700,892
-38,013
| -5% | -$1.93M | 0.23% | 66 |
|
|
2016
Q4 | $35.6M | Buy |
738,905
+71,946
| +11% | +$3.55M | 0.23% | 67 |
|
|
2016
Q3 | $36M | Buy |
666,959
+18,373
| +3% | +$1.01M | 0.24% | 64 |
|
|
2016
Q2 | $35.1M | Buy |
648,586
+30,169
| +5% | +$1.59M | 0.24% | 62 |
|
|
2016
Q1 | $31.3M | Buy |
618,417
+29,019
| +5% | +$1.45M | 0.22% | 71 |
|
|
2015
Q4 | $29.7M | Buy |
589,398
+2,772
| +0.5% | +$141K | 0.23% | 71 |
|
|
2015
Q3 | $28.2M | Buy |
586,626
+69,135
| +13% | +$3.6M | 0.21% | 73 |
|
|
2015
Q2 | $26.9M | Buy |
517,491
+154,516
| +43% | +$8.7M | 0.18% | 76 |
|
|
2015
Q1 | $20.9M | Buy |
362,975
+54,277
| +18% | +$3.11M | 0.14% | 80 |
|
|
2014
Q4 | $16.5M | Buy |
308,698
+22,291
| +8% | +$1.25M | 0.1% | 87 |
|
|
2014
Q3 | $16.5M | Sell |
286,407
-15,235
| -5% | -$934K | 0.1% | 90 |
|
|
2014
Q2 | $20.2M | Buy |
301,642
+2,388
| +0.8% | +$162K | 0.11% | 85 |
|
|
2014
Q1 | $20M | Buy |
299,254
+9,072
| +3% | +$613K | 0.12% | 83 |
|
|
2013
Q4 | $19.4M | Buy |
290,182
+5,772
| +2% | +$374K | 0.11% | 83 |
|
|
2013
Q3 | $17.8M | Buy |
284,410
+17,698
| +7% | +$1.14M | 0.1% | 86 |
|
|
2013
Q2 | $16.7M | Buy |
+266,712
| New | +$16.9M | 0.1% | 82 |
|
Other funds holding GSK
JEST
